On the other hand, decreased expression of TRPV5 in tumour tissues was observed in non-small cell lung cancer patients and was associated with a shorter median survival time after surgical resection [15], and different expression levels of TRPV5 were detected among the different RCC histopathological subtypes that arise from different origins [16]. Here, TRPV5 is linked to non-small cell lung carcinoma.